Reactive Gliosis as a Consequence of Interleukin-6 Expression in the Brain: Studies in Transgenic Mice
The DOI matches its Crossref record.
Abstract
Gliosis is a characteristic pathologic state in many CNS disorders. Cytokines are considered to be effectors of gliosis. In order to explore the role of IL-6 in gliosis, the temporal and spatial expression of the IL-6 gene and its consequent effects on the brain were studied in a GFAP-IL6 transgenic mouse model. In GFAP-IL6 mice, IL-6 transgene expression was detectable in the brain at 1 week postnatally and increased to maximal levels by 3 months of age before declining at 8 and 12 months. Enhanced glial fibrillary acidic protein (GFAP) (marker for astrocytes) and Mac-I (marker for microglia) mRNA expression were first prominent at 1 month, increased to maximum levels by 3 months and remained significantly elevated through 12 months of age. Western blot analysis revealed that the enhanced GFAP mRNA expression in these transgenic mice was accompanied by increased GFAP protein levels. Immunostaining for Mac-I demonstrated that in addition to an increased staining intensity, the number of cells expressing the microglial/macrophage marker was also apparently increased, particularly in the cerebellum and brain stem. Concurrent with IL-6 transgene mRNA expression and reactive gliosis, upregulation of IL-1 alpha/beta, TNF alpha, ICAM-1 and EB22/5.3 (acute-phase reactant) but not inducible nitric oxide synthase gene expression was also observed. EB22/5.3 mRNA expression was most prominent and increased progressively with age. Expression of the IL-6, GFAP and EB22/5.3 RNAs was found to have similar distribution in the brain being found predominantly in the cerebellum, brain stem and sub-cortical regions. In conclusion, the constitutive expression of IL-6 in the brain induced the development of a pronounced and lifelong reactive gliosis affecting both astrocytes and microglia. The altered state of these cells may contribute to the functional and structural CNS impairment exhibited by the GFAP-IL6 mice. Finally, in these mice, expression of the EB22/5.3 gene correlated closely with the progression of neuropathy indicating that this acute-phase response gene was a good marker for and may be involved in the pathogenesis of CNS injury mediated by the expression of IL-6.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
Ershler, W. B., & Keller, E. T. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.245 · Cited by 1,282
Interleukin-6, a Major Cytokine in the Central Nervous System
Erta, M., Quintana, A., & Hidalgo, J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4679 · Cited by 1,087
Fitch, M. T., & Silver, J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.014 · Cited by 1,007
Vallières, L., Campbell, I. L., Gage, F. H., & Sawchenko, P. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00486.2002 · Cited by 600
Self-citationAstrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke
Liu, Z., & Chopp, M. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.008 · Cited by 590
Interleukin-6 (IL-6)—A molecule with both beneficial and destructive potentials
Gadient, R. A., & Otten, U. H. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00021-x · Cited by 481
Physiological and pathological roles of interleukin-6 in the central nervous system
Gruol, D. L., & Nelson, T. E. (1997) · Molecular Neurobiology · doi:10.1007/bf02740665 · Cited by 404
Heyser, C. J., Masliah, E., Samimi, A., Campbell, I. L., & Gold, L. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1500 · Cited by 386
Self-citationAngeles Muñoz-Fernández, M., & Fresno, M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00045-8 · Cited by 367
Interleukin-6, a mental cytokine
Spooren, A., Kolmus, K., Laureys, G., Clinckers, R., De Keyser, J., Haegeman, G., & Gerlo, S. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.002 · Cited by 352
Central neuron–glial and glial–glial interactions following axon injury
Aldskogius, H., & Kozlova, E. N. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00093-2 · Cited by 352
Induction of acute phase gene expression by brain irradiation
Hong, J.-H., Chiang, C.-S., Campbell, I. L., Sun, J.-R., Withers, H. R., & McBride, W. H. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00279-8 · Cited by 349
Self-citationBuffo, A., Rolando, C., & Ceruti, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.014 · Cited by 321
The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury
Hannila, S. S., & Filbin, M. T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.020 · Cited by 288
Gomes, W. A., Mehler, M. F., & Kessler, J. A. (2003) · Developmental Biology · doi:10.1016/s0012-1606(02)00037-4 · Cited by 279
Fitch, M. T., & Silver, J. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6701 · Cited by 269
Fumagalli, F., Gainetdinov, R. R., Valenzano, K. J., & Caron, M. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04861.1998 · Cited by 266
Inflammation in Traumatic Brain Injury: Role of Cytokines and Chemokines
Ghirnikar, R. S., Lee, Y. L., & Eng, L. F. (1998) · Neurochemical Research · doi:10.1023/a:1022453332560 · Cited by 261
Vallières, L., & Rivest, S. (1999) · Endocrinology · doi:10.1210/endo.140.9.6983 · Cited by 157
Ladenheim, B., Krasnova, I. N., Deng, X., Oyler, J. M., Polettini, A., Moran, T. H., Huestis, M. A., & Cadet, J. L. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1247 · Cited by 131
“The prominent neurodegeneration observed in transgenic mice that chronically overexpress IL-6 provide very cogent support for the idea of IL-6 as a pro-toxin (Campbell et al., 1993; Chiang et al., 1994).”
Apaijai, N., Moisescu, D. M., Palee, S., McSweeney, C. M., Saiyasit, N., Maneechote, C., Boonnag, C., Chattipakorn, N., & Chattipakorn, S. C. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010838 · Cited by 90
Petković, F., Campbell, I. L., Gonzalez, B., & Castellano, B. (2016) · Glia · doi:10.1002/glia.23043 · Cited by 59
“In has been reported previously that GFAP-IL6Tg mice are characterized by reactive gliosis, which correlates with the production of IL-6 in these mice (Campbell et al., 1993; Chiang et al., 1994).”
BackgroundSelf-citationPetković, F., Campbell, I. L., Gonzalez, B., & Castellano, B. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.07.003 · Cited by 20
Self-citationComes, G., Manso, Y., Escrig, A., Fernandez-Gayol, O., Sanchis, P., Molinero, A., Giralt, M., Carrasco, J., & Hidalgo, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020251 · Cited by 10
“Iba-1 levels were increased by Mt1 overexpression in old male mice but decreased in young males; the latter also showed decreased GFAP levels.”
BackgroundInfluential
Metadata
- Authors
- Chiang, C.-S., Stalder, A., Samimi, A., & Campbell, I. L.
- Venue
- Developmental Neuroscience
- Publisher
- S. Karger AG
- Published
- 1994
- Volume
- 16
- Issue
- 3-4
- Pages
- 212-221
- ISSN
- 0378-5866 (ISSN-L)
- 1421-9859
- OpenAlex
- W2081489881
- Cited by
- 241
- References
- 0
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.